- GlobeNewswire•2 days ago
NORCROSS, Ga., Dec. 08, 2016-- Galectin Therapeutics Inc., the leading developer of therapeutics that target galectin proteins, today announced that the Company will present a corporate update via live ...
- Investopedia•29 days ago
Galectin reported promising results from a trial of its plaque psoriasis drug.
- GlobeNewswire•last monthGalectin Therapeutics Announces Positive New Psoriasis and Atopic Dermatitis Clinical Data, Seeking Strategic Partnerships for Therapy of Severe Skin Diseases
NORCROSS, Ga., Nov. 10, 2016-- Galectin Therapeutics Inc., the leading developer of therapeutics that target galectin proteins, today announced its plans to identify a strategic partnership for its galectin-3 ...
GALT : Summary for Galectin Therapeutics Inc. - Yahoo Finance
Galectin Therapeutics, Inc. (GALT)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||0.55 x 6000|
|Ask||4.14 x 1500|
|Day's Range||0.90 - 1.03|
|52 Week Range||0.49 - 3.05|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.24|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|